BSH 2023 | Session highlights: top abstracts in red cell disorders
Subarna Chakravorty, MBBS, MRCPCH, FRCPath, PhD, King’s College Hospital NHS Foundation Trust, London, UK, shares some insights into a session held at BSH 2023 which focused on red cell disorders. Topics that were covered in this session include novel agents and ongoing studies in paroxysmal nocturnal hemoglobinuria (PNH), novel agents in sickle cell disease (SCD), and updates in thalassemia in the UK. This interview took place at the 63rd Annual Scientific Meeting of the British Society for Haematology (BSH) 2023, held in Birmingham, UK.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Disclosures
Vertex, Novartis, GBT, Forma Therapeutics – Advisory Board
